Next Article in Journal
Ultrasound-Assisted Extraction of Alginate from Fucus vesiculosus Seaweed By-Product Post-Fucoidan Extraction
Next Article in Special Issue
The Identification and Characterization of a Novel Alginate Lyase from Mesonia hitae R32 Exhibiting High Thermal Stability and Potent Antioxidant Oligosaccharide Production
Previous Article in Journal
Biodiversity and Hemolytic Toxicity of the Genus Heterocapsa (Dinophyceae) in the Beibu Gulf, China
Previous Article in Special Issue
Direct Preparation of Alginate Oligosaccharides from Brown Algae by an Algae-Decomposing Alginate Lyase AlyP18 from the Marine Bacterium Pseudoalteromonas agarivorans A3
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effects of Agaro-Oligosaccharides Produced by Marine Bacteria (Rheinheimera sp. (HY)) Possessing Agarose-Degrading Enzymes on Myotube Function

1
Graduate School of Fisheries and Environmental Sciences, Nagasaki University, Nagasaki 8528521, Japan
2
Department of Marine Biotechnology, National Kaohsiung University of Science and Technology, Kaohsiung 811213, Taiwan
3
Organization for Marine Science and Technology, Nagasaki University, Nagasaki 8528521, Japan
*
Author to whom correspondence should be addressed.
Mar. Drugs 2024, 22(11), 515; https://doi.org/10.3390/md22110515
Submission received: 1 October 2024 / Revised: 13 November 2024 / Accepted: 13 November 2024 / Published: 14 November 2024
(This article belongs to the Special Issue Marine Proteins and Enzymes: Bioactivities and Medicinal Applications)

Abstract

:
Agarase and its metabolites are reported to have applications in a variety of fields, but there have been few studies of the effects of agaro-oligosaccharide hydrolysate on muscle function. In this study, we analyzed the functionality of agarase and its metabolites in bacteria isolated from seawater. A bacterium with agar-degrading activity was isolated from Shimabara, Nagasaki, Japan. Through 16S rRNA sequence alignment, it was identified as being closely related to Rheinheimera sp. WMF-1 and was provisionally named Rheinheimera sp. (HY). Crude enzymes derived from this bacterium demonstrated an ability to hydrolyze various polysaccharides, including agar, agarose, and starch, with the highest specificity observed for agarose. The optimum pH and temperature were pH 10 and 50 °C. A glycoside bond specificity analysis of enzymatic activity indicated the cleavage of the α-linkage. Next, we investigated the functional effects of agaro-oligosaccharides on C2C12 myotubes. Treatment with 10–30 kDa oligosaccharides significantly increased the hypertrophy rate, diameter, and expression of myosin heavy-chain genes in C2C12 myotubes. These results indicate that the agaro-oligosaccharides produced by the enzymes identified in this study improve muscle mass, suggesting their potential contribution to muscle function.

1. Introduction

Polysaccharides are derived from plants, microbes, animals, and algae. Alginate, a polysaccharide of high molecular weight, has been isolated from red and brown algae. The main types of polysaccharides include agar, guar, keratin, alginate, carrageenan, gum arabic, starch, and pectin [1]. Agar has been used as a food source in Japan for several centuries. During the seventeenth and eighteenth centuries, its use spread from Japan to other East Asian countries [2]. It is also known as agar-agar, and is a polysaccharide obtained from the cell walls of red algae (Rhodophyta). It is composed of approximately 70% agarose (also referred to as neutral agar), which contains approximately 2% sulfate groups, and 30% agaropectin (also known as acidic agar), which contains approximately 20% sulfate groups. Agar is a mixture of these two polysaccharides, agarose and agaropectin [2].
Agarases are enzymes capable of hydrolyzing agar derived from sources such as seawater, marine sediments, and seaweeds. This enzyme can hydrolyze or soften agar, leading to phenomena such as surface depression or the formation of clear zones. As shown in Figure 1, agarases can be classified based on their action on various glycosidic bonds. α-agarase (EC 3.2.1.158) can hydrolyze α-(1→3) linkages to produce agaro-oligosaccharides (AOS) [3]. β-agarase (EC 3.2.1.81) can hydrolyze β-(1→4) linkages to produce neoagaro-oligosaccharides (NAOS) with β-d-galactose at the reducing end [4,5,6]. The hydrolysis products of these enzymes are primarily 3,6-anhydro-l-galactose and d-galactose [2].
Rheinheimera sp. encompasses a diverse group of Gram-negative bacteria found in various environments, such as seawater, brackish water, and sediments. These bacteria exhibit various characteristics, such as being aerobic, rod-shaped, and motile, with varying optimal growth conditions in terms of temperature, pH, and salinity [7,8,9]. They are known for their biofilm-forming abilities, which can affect the working of devices such as reverse osmosis modules, making them a focus of research on biofouling and anti-fouling strategies [10]. Additionally, some Rheinheimera strains have been identified as multidrug-resistant, containing genomic islands with antibiotic resistance genes and arsenic tolerance operons, highlighting their potential role in environmental antibiotic and arsenic pollution, and the spread of resistance genes [11]. Furthermore, Rheinheimera sp. has attracted attention because of its various useful enzymes. However, no studies have reported on agarases derived from Rheinheimera sp.
Polysaccharide mixtures containing AOS demonstrate stability due to their interaction with proteins owing to their anionic characteristics and the three-dimensional network structure of polysaccharides [12]. Despite being poorly digestible oligosaccharides, recent studies have demonstrated their potential contribution to human health. These include anticancer properties [13], antitumor effects [14], skin whitening [15], anti-inflammatory effects [15], anti-obesity effects [16], anti-fatigue properties [17], hepatoprotective effects [18], antioxidant activity [18], prebiotic function [19], and the attenuation of smooth muscle cell contraction [20]. These activities are associated with the chemical structure, molecular weight, degree of polymerization, and glycosidic bond positions of the oligosaccharides [21]. Among the studies reported thus far, only one, conducted by Shirai et al., has examined the effects of AOS on muscle recovery. That study demonstrated that AOS prevent myotube shrinkage induced by tumor necrosis factor (TNF)-α, a pro-catabolic factor, by maintaining myosin heavy-chain (MyHC) protein levels and normalizing myostatin mRNA expression [20]. Furthermore, no study has explored the effects of AOS produced by enzymes derived from Rheinheimera, and no study has investigated the effects of AOS produced by enzymes derived from Rheinheimera on muscle function. In this study, we examine the effects on muscle function of oligosaccharides produced by newly identified marine bacteria.

2. Results

2.1. The Hydrolytic Ability of Rheinheimera sp. (HY) on Polysaccharides

This study initially aimed to identify agar-degrading marine bacteria in Shimabara, Nagasaki, Japan. Through a screening of crude extracts, we found that agarases produced by marine bacteria demonstrated the highest activity at various pH values, even in the presence of metal ions.
The DNA of the selected agarase-producing hydrolytic strains was extracted by high-temperature cell lysis and used as a template. The 16S rRNA conserved sequence primer 16S-F/16S-R was used to amplify the 16S rRNA fragment. The obtained sequences were analyzed using the Basic Local Alignment Search Tool (BLAST) program in the National Center for Biotechnology Information (NCBI) database. The analysis revealed that the selected strains showed similarities of 93.68% to Rheinheimera sp. WMF-1 (accession no. AM690025.1). For subsequent experiments, Rheinheimera sp. WMF-1 will be renamed Rheinheimera sp. (HY). After picking colonies with a strong hydrolysis ability (obvious depressions) and conducting a streak culture to obtain single pure colonies (Figure 2A,B), it was found that Rheinheimera sp. (HY) exhibited hydrolytic activity on agar, agarose, and starch (Figure 2C).

2.2. Biochemical Characterization of Crude Enzyme

2.2.1. Substrate Specificity of Crude Enzyme

Three polysaccharides, agar, soluble starch, and agarose, were chosen as the reaction substrates. The 3,5-dinitrosalicylic acid (DNS) method was used to measure the reducing sugar content and determine enzyme activity, investigating the substrate specificity of the crude enzyme (Table 1). The substrate with the highest activity was assigned a relative activity of 100%, and the activities of other substrates were expressed as relative percentages. The results showed that the crude enzyme had the highest catalytic activity against agarose, followed by agar and starch.

2.2.2. Optimal Temperature and pH of Crude Enzyme Activity

In this experiment, agarose, the substrate with the highest relative activity, was used as the reaction substrate. The highest activity measured at each temperature and pH was set to 100%, and the agarase activities measured at other temperatures were expressed as relative percentages. The results showed that the catalytic activity of the crude enzyme increased with the increasing temperature, with an optimal reaction temperature of 50 °C. When the temperature was raised to 60 °C, the relative activity decreased to 53.7% (Figure 3A). The optimal pH for crude enzyme activity was 10. Activity remained relatively high between pH 6.0 and pH 11.0, retaining more than 95% of its residual activity and exhibiting considerable pH stability across a wide range of values. A statistical analysis revealed no significant differences in the enzyme activity across pH 6, 7, 8, 9, 10, and 11, with peak activity at pH 6.0. Additionally, using the pH 6.0 buffer, significant differences in the enzyme activity were observed when comparing pH 3, 4, and 5, which showed lower stability. In contrast, the enzyme remained stable and active across the broader pH range of 6 to 11. At pH = 3.0, the relative activity decreased to 65.8% (Figure 3B).

2.2.3. Effects of Chemicals on Crude Enzyme Activity

Agarose was used as the substrate in this experiment. The experimental results showed that manganese sulfate (MnSO4) and ferrous sulfate (FeSO4) significantly increased the activity of the crude enzyme by 184.98% and 580.73%, respectively, while the addition of potassium chloride (KCl), sodium chloride (NaCl), urea, sodium dodecyl sulfate (SDS), and ethylenediaminetetraacetic acid (EDTA) resulted in a decrease in agarase activity (Table 2). EDTA, a metal chelator, inhibits metalloproteases. Both high and low concentrations of EDTA inhibited the activity of the crude enzyme, suggesting that the enzyme studied in this experiment is a metalloenzyme. Treatment with 5 mM SDS significantly inhibited agarase activity, likely due to the disruption of the enzyme’s hydrophobic bonds. The addition of the urea denaturant interacts with the cell wall and cell membrane, and the addition of the curing enzyme reduces the permeability of certain proteins inside and outside the cell, as well as the activity of proteases on the cell membrane. Additionally, urea might disrupt the enzyme’s hydrophilic bonds, resulting in reduced activity.

2.2.4. Analysis of Hydrolytic Activity of Agarase in Crude Enzymes

This study investigated the hydrolytic activity of crude enzymes on different glycosidic bonds. Two artificial substrates, p-nitrophenyl-α-d-galactopyranoside (which is cleaved by enzymes that hydrolyze α-glycosidic bonds) and p-nitrophenyl-β-d-galactopyranoside (which is cleaved by enzymes that hydrolyze β-glycosidic bonds), were used for activity measurements. The results showed an increase in agarase activity towards α-form and β-form glycosidic bonds (Table 3), suggesting a higher activity specifically towards α-form glycosidic bonds.

2.3. Agaro-Oligosaccharides (AOS) on Mouse C2C12 Myotubes

2.3.1. AOS on C2C12 Cell Viability

Figure 4 shows the effects of AOS on viability, using mixtures of AOS with differing molecular weights (<10 kDa, 10–30 kDa, and >30 kDa). The mixture was treated at a concentration of 2000 µg/mL. When AOS was added for 24 h, the 10–30 kDa fraction-treated C2C12 differentiated myotubes exhibited a 53% increase in viability, as indicated by the absorbance at 450 nm, compared to the control group, which was set at 100%.

2.3.2. Effect of AOS on Diameters of Myotubes

To analyze the effects of AOS on the diameters of C2C12 myotubes, 10 images per group of myotube cultures were taken, using a phase-contrast microscope at 20× magnification. Myotube diameters were measured for a total of 20 myotubes from 10 fields using the BZ-II Analyzer software (BZ-7228 Keyence, Osaka, Japan), selecting the thickest portion of each myotube for measurement. The oligosaccharide mixture was treated at a concentration of 2000 µg/mL, and 2% horse serum (HS)/Dulbecco’s modified Eagle medium (DMEM) was used as the controls. Figure 5A shows microscopic images of the myotubes subjected to each treatment (AOS mixture treatment (2000 µg/mL) <10 kDa; 10–30 kDa; >30 kDa; 2% HS/DMEM medium-only control). The average diameter of the myotubes without any additives (2% HS/DMEM control) was 16.7 μm. When AOS > 30 kDa was added, the diameter was about 20.6 μm. The addition of AOS of 10–30 kDa resulted in a diameter of approximately 24.5 μm, while AOS < 10 kDa resulted in a diameter of about 20.6 μm. Compared to the control, the addition of 10–30 kDa AOS significantly increased the myotube diameter (Figure 5B).

2.3.3. Relative mRNA Expression of the Genes Related to Muscle Synthesis

The MyHC composition plays a crucial role in muscle hypertrophy. Myosin is a crucial component of force-generating units in eukaryotic cells. Through ATPase activity, myosin undergoes conformational changes and binds to actin filaments, thereby producing a driving force for muscle contraction and cell movement. Myosin consists of the products of three types of genes: myosin heavy-chain, myosin light-chain, and myosin regulatory light-chain. Among these, myh3, myh4, and myh7 are predominantly expressed in skeletal muscles, whereas the non-muscle myosin genes, myh9, are located as single genes on chromosomes 5 and 11. myh3 and myh7 are expressed during mouse and human embryonic development, respectively. While myh3 expression decreases postnatally, myh7 expression persists in adult muscle. In adult skeletal muscles, myh7 is predominantly expressed in slow muscle fibers, whereas myh4 is expressed in fast muscle fibers. myh3 is not expressed in adult muscle under normal conditions, but is activated during muscle regeneration. Consequently, the expression profile of myh genes and their encoded proteins serves as a signature for specific cell types, fiber types, and the regenerative status of skeletal muscles [22].
Figure 6 shows the effect of AOS on the mRNA expression of muscle molecular motors in C2C12 myotubes. The expression levels were compared to the control group, which consisted of C2C12 myotubes cultured without AOS. Compared to the control group without AOS, the 10–30 kDa AOS significantly increased the mRNA expression of the muscle molecular motors, myh3, myh4, and myh7. Although myh9 also showed an increase in mRNA expression with 10–30 kDa AOS, it was not statistically significant.

3. Discussion

The crude enzyme secreted by this bacterium has broad substrate specificity, exhibiting activity towards agar, agarose, and starch (Figure 2). Previous studies have identified multifunctional enzymes with diverse activities, such as amylase, carrageenase, and neoagarobiose hydrolase, thereby expanding their application range [23,24,25]. For example, a novel multifunctional enzyme, Amy63, isolated from Vibrio alginolyticus 63, exhibits amylase, agarase, and carrageenase activity, facilitating substrate degradation across starch, carrageenan, and agar [25]. Another marine bacterium, Halomonas meridiana, has agarase, amylase, and xylanase hydrolase activities [26].
The characterization of Rheinheimera sp. (HY) revealed that its enzyme exhibits optimal activity at pH 10.0 and a temperature of 50 °C (Figure 3). Different agarase enzymes exhibit specific activities and different optimal pH and temperature ranges for activity. For instance, agarase from the Acinetobacter strain PS12B showed an optimal pH of 8.0 and a temperature of 40 °C, respectively [27]. AgWH50B from Agarivorans gilvus WH0801 displayed optimal conditions, which were pH 7.0 and 40 °C [28]. CaAga1 from Cellulophaga algicola DSM 14237 exhibited specific activities towards different agar sources and had an optimal pH of 7 and a temperature of 40 °C, with stability over a wide pH range [29]. Rheinheimera sp. (HY) adapts to a wide pH range of 6.0–10.0, maintaining more than 90% of its maximum activity throughout this range. Although the pH range is inconsistent, depending on the strains with agarase in different genera, the minimum values range widely from the maximum values, such as Thalassomonas sp. JAMB-A33, Catenovulum sp. X3, and Vibrio sp. AP-2 [30].
The effects of various chemical reagents on Rheinheimera sp. (HY) were also investigated. Notably, MnSO4 and FeSO4 enhanced the agarase activity (Table 2). The high activity observed may be attributed to the presence of MnSO4 and FeSO4 in the culture medium of Rheinheimera sp. (HY). MnSO4 has been shown to have varying effects on the crude agarase enzyme activity. Research indicates that MnSO4 can inhibit the activity of agarase enzymes, with results showing decreased activity when exposed to metal ions, such as manganese [31,32]. Additionally, the presence of MnSO4 can lead to secondary reactions that may affect the catalytic activities of enzymes, thereby affecting their overall performance [33].
According to a previous study, the addition of different concentrations of AOS mixtures (0.625, 2.5, and 10 µg/mL) did not lead to significant differences in muscle cell proliferation [19]. Furthermore, AOS does not exhibit cytotoxic effects in mammalian cells [20,34]. We found that the addition of the 10–30 kDa AOS fraction significantly increased cell viability (Figure 4), which may indicate enhanced mitochondrial activity, and also significantly increased the myotube diameter (Figure 5 and Figure 6). Additionally, the 10–30 kDa AOS fraction significantly increased the mRNA expression of the myosin heavy-chain genes myh3, myh4, and myh7 (Figure 6). The process by which oligosaccharides are taken up by muscle cells involves several steps and mechanisms. Although the exact pathway for AOS specifically might not be fully elucidated, the general process for oligosaccharide uptake and utilization can be described as follows. For example, glucose, a monosaccharide, is absorbed in the small intestine through specific transporters such as sodium–glucose-linked transporter 1 (SGLT1) and glucose transporter 2 (GLUT2). Once in the bloodstream, glucose is transported to muscle cells, where it is taken up by GLUT4 in response to insulin signaling. Inside muscle cells, glucose is metabolized through glycolysis to produce adenosine triphosphate (ATP) or stored as glycogen for future energy needs. This general framework of absorption, transport, and cellular uptake provides a basis for understanding how other oligosaccharides might be processed in the body [35,36]. In C2C12 cells, a model for muscle cell proliferation, it is important to consider how AOS may affect the glucose uptake and metabolism during the proliferating phase. Shirai et al. showed that AOS protects against myostatin overexpression and myosin heavy-chain degradation under inflammatory conditions, suggesting their potential role in regulating energy homeostasis and cell cycle pathways [20]. Future research should explore how AOS interacts with the glucose metabolism and insulin signaling in proliferating muscle cells to elucidate their effects on cell growth and differentiation.
Hong et al. showed that the treatment of Melan-a, derived from immortalized melanin synthesis cells, with neoagarooligosaccharides at concentrations up to 2000 µg/mL showed no significant changes in cell viability, with high survival rates observed [37]. Additionally, the neoagarooligosaccharide mixture at 4000 µg/mL also maintained a high cell survival rate of approximately 80% [37]. In our studies using HeLa cervical cancer cells, no changes in cell viability were observed even at a high concentration of 2500 µg/mL. In this study, although at high concentrations, we increased the concentration to 2000 µg/mL to ensure that any potential effects could be observed more clearly. This suggests that the concentration of AOS might be reduced by further purification. Further research is needed to evaluate the effects of AOS in future studies.
In the future, further staining with a nuclear marker will be required to accurately calculate the myotube diameter. The myotube analyzer can be used to analyze fixed differentiated myoblast cultures by nuclear and MyHC staining, enabling the assessment of physiological effects on muscle growth and metabolism by measuring relevant biomarkers and conducting histological analyses of muscle tissues. In addition, in vivo experiments should focus on administering oligosaccharides via oral, intravenous, or intraperitoneal routes. Their absorption, distribution, metabolism, and excretion should be carefully monitored to evaluate their bioavailability and pharmacokinetics. These studies will help elucidate the mechanisms by which AOS affect the muscle physiology and determine the most effective administration route for potential therapeutic applications.

4. Materials and Methods

4.1. Bacterial Isolation and Identification from Seawater

Seawater samples were collected from Shimabara City, Nagasaki Prefecture, Japan. The seawater was aspirated using a syringe needle and filtered through a 0.22 µm filter membrane. This filtration process was repeated three or four times. The filter membrane was then placed in a pre-sterilized liquid culture medium (NaNO3, K2HPO4, MgSO4, CaCl2, NaCl, FeSO4, MnSO4, and agar), incubated for 48 h at 30 °C, and shaken at 160 rpm. The cultured bacterial solution was subsequently diluted tenfold, and the diluted culture was spread onto a solid culture medium. The plates were incubated at 30 °C for 48 h. Sunken colonies were selected and purified using the streak plate method. The 16S rRNA gene fragment was amplified by a polymerase chain reaction (PCR) using primers specific to the conserved sequence of the 16S rRNA gene in prokaryotic organisms (16S-F/16S-R) for a strain identification analysis. The nucleotide primers used for PCR were as follows: 5′- ATGGTTTGATCATGGCTCAGATT-3′ for 16S-F and 5′- TCAGGTTACCTTGTTACGACTT-3′ for 16S-R. After confirming the quality of the PCR products, a DNA sequence analysis was conducted (Fasmac, Atsugi, Japan). The 16S rRNA gene sequences of the strains were compared using the BLAST program in the NCBI database.

4.2. Hydrolytic Ability of Bacteria

For plate-based activity assays of marine bacteria, a sterile toothpick was used for the selection of a single colony; bacteria were punctured in plates on a middle containing 0.3% agar, 0.3% agarose, and soluble starch with 1.5% agar, respectively. The plates were maintained at 30 °C for 48 h. Plates containing agar, agarose, and starch for checking multifunctional enzyme activities were stained with Lugol’s iodine solution, and the clear zone around the hole was visualized.

4.3. 3,5-Dinitrosalicylic Acid (DNS) Assay

The reducing sugar content was determined using 3,5-dinitrosalicylic acid (DNS), an aromatic compound that reacts with reducing sugars. Briefly, the procedure was as follows. Under continuous stirring, 1.6 g NaOH was added to 75 mL of distilled water, followed by 3,5-dinitrosalicyclic acid. To create 100 mL of DNS reagent, 3 g of sodium potassium tartrate was added, and the remaining volume was filled with distilled water [38].

4.4. Production of Crude Enzyme

The bacterial suspension was stored at −80 °C, and at the time of the experiment, it was rapidly thawed at room temperature until completely melted. A 0.5 mL portion of the bacterial solution–glycerol mixture was added to 15 mL of medium containing 0.1% agar, incubated at 30 °C, and shaken at 160 rpm for approximately 18 h. When the OD600 reached 0.8, 15 mL of the bacterial solution was transferred to 50 mL of medium containing 0.3% agar, incubated at 25 °C, and shaken at 160 rpm for 24 h. The culture solution was then centrifuged at 12,000× g for 10 min at 10 °C using a Nalgene centrifuge. The supernatant was concentrated and purified using 30 kDa Vivaspin (Vivaproducts, Littleton, MA, USA) at 5000 rpm for 10 min at 15 °C, and this was used as the crude enzyme for biochemical characterization.

4.5. Substrate Specificity of Crude Enzyme

In this experiment three polysaccharides, agar, agarose, and soluble starch, were chosen as reaction substrates. The activity was determined by using the 3,5-dinitrosalicylic acid (DNS) method. The yellow DNS reagent is reduced to a reddish-brown compound in the presence of reducing sugars. The color intensity of the reaction product is proportional to the concentration of reducing sugars, which can be measured by absorbance at 540 nm. Briefly, a 0.3% polysaccharide solution was prepared, and 400 µL of this solution was added to 200 µL of the crude enzyme. The mixture was reacted at 30 °C for 30 min to promote enzyme activity. Then, 400 µL of DNS reagent was added, and the mixture was reacted in boiling water at 100 °C for 10 min before being immediately cooled on ice. The reaction solution was placed in a 96-well plate, and the absorbance at 540 nm was measured using a microplate reader (BioTek Cytation 3, Winooski, VT, USA). Relative activity was calculated by setting the highest activity among the different substrates to 100%, and the activities of the other substrates were expressed as relative percentages.

4.6. Optimal Temperature of Crude Enzyme

In order to identify the optimal temperature for crude enzyme activity, 20 mM Na2HPO4/citric acid buffer at pH 6.0 was incubated at various temperatures (10 °C, 20 °C, 30 °C, 40 °C, 50 °C, 60 °C, and 70 °C) for 5 min. Subsequently, 200 µL of crude enzyme and 400 µL of the substrate solution were added. The reaction was carried out at the specified temperatures for 30 min. After the reaction, 400 µL of DNS reagent was added, and the mixture was heated in boiling water at 100 °C for 10 min and then immediately cooled on ice. The reaction solution was placed in a 96-well plate, and the absorbance at 540 nm was measured using a microplate reader (BioTek Cytation 3, Winooski, VT, USA). The highest activity measured at different reaction temperatures was set to 100%, and the activities at other temperatures were expressed as relative percentages.

4.7. Optimal pH of Crude Enzyme

To determine the optimal pH for crude enzyme activity, various buffers were prepared: 20 mM Na2HPO4/citric acid buffer (pH 3.0–5.0), 20 mM Na2HPO4/NaH2PO4 buffer (pH 6.0–7.0), 20 mM Tris/HCl buffer (pH 8.0–9.0), and 20 mM glycine/NaOH buffer (pH 10.0–11.0). Each buffer (400 µL) was mixed with 200 µL of the crude enzyme and 400 µL of the substrate solution (0.3% agar solution) in a 2.0 mL Eppendorf tube. The reactions were conducted at 30 °C for 30 min. After the reaction, 400 µL of DNS reagent was added, and the mixture was heated in boiling water at 100 °C for 10 min and then immediately cooled on ice. The reaction solution was placed in a 96-well plate, and the absorbance at 540 nm was measured using a microplate reader (BioTek Cytation 3, Winooski, VT, USA). The highest activity measured at different pH values was set to 100%, and the activities at other pH levels were expressed as relative percentages.

4.8. Effect of Chemicals on the Crude Enzyme

To determine the effects of various additives on the activity of the crude enzyme, 5 mM solutions of KCl, MnSO4, FeSO4, NaCl, urea, SDS, and EDTA were prepared using 20 mM Na2HPO4/citric acid buffer (pH 6.0). In a 2.0 mL Eppendorf tube, 400 µL of the 5 mM additive solution, 200 µL of the crude enzyme, and 400 µL of the substrate solution were combined. The reaction mixture was prepared to ensure that the final concentration of each additive was 5 mM throughout the reaction. The reaction was conducted at 30 °C for 30 min. Subsequently, 400 µL of DNS reagent was added, and the mixture was heated in boiling water at 100 °C for 10 min and then immediately cooled on ice. The reaction solution was placed in a 96-well plate, and the absorbance at 540 nm was measured using a microplate reader (BioTek Cytation 3, Winooski, VT, USA). The highest activity measured without additives was set to 100%, and the activities with additives were expressed as relative percentages.

4.9. Glycosidic Bonds of Crude Enzyme Activity

Agarases are classified into α-agarases and β-agarases based on the type of glycosidic bond they hydrolyze. To determine enzyme specificity, artificial chromogenic substrates such as p-nitrophenyl-α-d-galactopyranoside and p-nitrophenyl-β-d-galactopyranoside were used. p-Nitrophenol is a yellow compound that absorbs light at 420 nm. The absorbance at this wavelength is directly proportional to the amount of p-nitrophenol released during the reaction. Briefly, 200 µL of crude enzyme and 400 µL of the artificial substrate were incubated at 30 °C for 2 h. The reaction was terminated by the addition of 400 µL of 1 M Na2CO3. A sample of the reaction solution was transferred to a 96-well plate, and the absorbance at 420 nm was measured using a microplate reader (BioTek Cytation 3, Winooski, VT, USA). The specific glycosidic bond hydrolyzed by the enzyme was determined based on the resulting absorbance.

4.10. Preparation of Agaro-Oligosaccharide

Stock cultures were preserved and added to 0.1% agar medium. The cultures were incubated at 30 °C and shaken at 160 rpm for 24 h. The 0.1% agar medium cultures were then transferred to a 0.3% agar medium and incubated under the same conditions (160 rpm, 30 °C) for 48 h. The cultures were centrifuged at 12,000× g for 10 min at 10 °C to separate the supernatant from the cell debris. The supernatant was concentrated using a Vivaspin centrifugal concentrator at 5000× g for 10 min at 15 °C. The concentrate was fractionated into three molecular weight ranges: <10 kDa, 10–30 kDa, and >30 kDa. The fractionated samples were then freeze-dried. The initial freeze-drying was conducted for 24 h, followed by a secondary freeze-drying for 48 h. Freeze-dried samples were dissolved in Milli-Q water. The oligosaccharide solutions so dissolved were filtered through a 0.22 μm filter to remove any remaining particulate matter. The filtered oligosaccharide solutions were stored at −80 °C.

4.11. Cell Culture

The C2C12 myoblast cells used in this study were purchased from the American Type Culture Collection (Rockville, MD, USA). C2C12 is a myoblast cell line derived from mice. They were cultured in DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin and incubated at 37 °C with 5% CO2. When the C2C12 myoblasts reached 100% confluence, the medium was changed to DMEM supplemented with 2% horse serum (HS). Cells were maintained in 2% HS/DMEM (differentiation medium) for three days for the formation of myotubes.

4.12. Cell Viability Assay

Cell viability was measured using the cell counting kit-8 (CCK-8) (Dojindo, Kumamoto, Japan). The CCK-8 assay measures cell viability based on the activity of cellular dehydrogenase enzymes. These enzymes reduce the water-soluble tetrazolium salt, WST-8, into a yellow-colored formazan product. The amount of formazan produced is directly proportional to the number of metabolically active (viable) cells in the sample. C2C12 myotubes were treated with AOS (final concentration: 2000 μg/mL) for 24 h. The culture medium was then removed, and the cells were washed three times with Hank’s balanced salt solution (HBSS) (Gibco, Grand Island, NY, USA). Following treatment with CCK-8 (10 μL/100 μL HBSS) in each well for 30 min, absorbance at the wavelength of OD450 nm was read using a microplate reader (BioTek Cytation 3, Winooski, VT, USA) and imager software (Version 6.1).

4.13. Measurement of Myotube Diameter

C2C12 myoblasts were plated in 24-well plates (5 × 104 cells/well) and then differentiated myotubes were treated with AOS (freeze-dried samples were dissolved in Milli-Q water (Millipore, Burlington, MA, USA)) at a final concentration of 2000 mg/mL for 24 h, after which they were photographed at ×20 magnification. The myotube diameters were of 20 randomly measured myotubes from 10 fields using the BZ Analyzer (Keyence, Osaka, Japan), selecting the thickest portion of each myotube for measurement. The oligosaccharide mixture was treated at a concentration of 2000 µg/mL, with 2% HS/DMEM for the control for C2C12. The BZ-H3C/Hybrid Cell Count option was used to measure the diameter of the myotubes. The exposure time was set to 1/50 s and images were acquired at a bit depth of 12 bit, black-and-white, using a BIOREVO BZ-X710 microscope (Keyence, Osaka, Japan).

4.14. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)

The total RNA was extracted from the cells using an acid guanidinium thiocyanate-phenol–chloroform mixture. A qRT-PCR analysis was performed with the appropriate primers and SYBR Green dye using a real-time PCR system (ABI Real-Time PCR Detection System; Applied Biosystems, Foster City, CA, USA) [39]. The mRNA levels were normalized to the housekeeping gene 18S ribosomal RNA. The oligonucleotide primers used for PCR were as follows: 5′- CCAACAGACTCCTGGCACAT-3′ and 5′- CTGAACAGTGCAGAGACGGT-3′ for myh3 (NM_001099635); 5′- GGAGTTCACACGCCTCAAAGAG-3′ and 5′- TCCTCAGCATCTGCCAGGTTGT-3′ for myh7 (NM_001361607); 5′- ATCCTGGAGGACCAGAACTGCA-3′ and 5′- GGCGAGGCTCTTAGATTTCTCC-3′ for myh9 (NM_022410); 5′- GACAGCCAAGAAGAGGAAACTGG-3′ and 5′- ACCTGCCATCTCTTCTGTGAGG-3′ for myh4 (NM_010855); and 5′- GTAACCCGTTGAACCCCATT-3′ and 5′- CCATCCAATCGGTAGTAGCG-3′ for mouse 18S. The qPCR parameters were set as follows: 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, and 60 °C for 1 min. The final melt curve analysis was conducted at 95 °C for 15 s, 60 °C for 1 min, and 95 °C for 15 s. Calculations for qPCR experiments were performed using absolute quantification.

4.15. Statistical Analysis

All data are represented as mean ± S.D. and were analyzed by a one-way or two-way analysis of variance (ANOVA) using IBM SPSS statistics version 26.0 software (Armonk, NY, USA), followed by Tukey’s test for individual differences between groups. Statistical significance was set at p < 0.05.

5. Conclusions

In this study we screened and identified agarase-producing bacterial strains in seawater samples, including Rheinheimera sp. (HY), that showed significant agarolytic activity. Optimal culture conditions for the strain were determined, and the best growth was observed at 30 °C on 0.1% agar. The biochemical characterization of the crude enzyme revealed the highest catalytic activity for agarose, with an optimal reaction temperature of 50 °C and a pH of 10.0. MnSO4 and FeSO4 notably enhanced enzyme activity, whereas other additives, such as KCl, NaCl, urea, SDS, and EDTA, reduced it. The enzyme demonstrated broad substrate specificity, hydrolyzed agar, agarose, and starch, and effectively broke down α-glycosidic and β-glycosidic bonds. Furthermore, this study explored the effects of AOS on mouse C2C12 myotubes, revealing that the 10–30 kDa agaro-oligosaccharide fraction significantly increased cell viability, the myotube diameter, and the expression of myosin heavy chains. These findings suggest that AOS can enhance the muscle fiber diameter following muscle differentiation. To better assess the myotube formation and the proliferation of myoblasts, future studies should incorporate a nuclear marker to calculate the fusion index, which would provide a more accurate measurement of myoblasts’ ability to differentiate into myotubes. These studies will help elucidate the mechanisms by which AOS affect the muscle physiology and determine the most effective administration route for potential therapeutic applications.

Author Contributions

Conceptualization, Y.H. and K.H.; methodology, Y.H., T.H., J.-M.T. and K.H.; software, K.H.; validation, Y.H., J.-M.T. and K.H.; formal analysis, Y.H. and K.H.; investigation, Y.H. and T.H.; resources, Y.H. and K.H.; data curation, Y.H. and K.H.; writing—original draft preparation, Y.H.; writing—review and editing, J.-M.T. and K.H.; visualization, Y.H.; supervision, K.H.; project administration, K.H.; funding acquisition, K.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported in part by grants from the Grant-in-Aid for Scientific Research of Japan (KAKENHI) (grant number: 23K10939).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

Abbreviations

ATPAdenosine triphosphate
AOSAgaro-oligosaccharides
BLASTBasic Local Alignment Search Tool
CCK-8Cell counting kit-8
DNS3,5-dinitrosalicylic acid
DMEMDulbecco’s modified Eagle medium
EDTAethylenediaminetetraacetic acid
FBSfetal bovine serum
FeSO4ferrous sulfate
GLUT2glucose transporter 2
HBSSHanks’ Balanced Salt Solution
HShorse serum
KClpotassium chloride
MnSO4manganese sulfate
myh3Myosin Heavy Chain 3
myh4Myosin Heavy Chain 4
myh7Myosin Heavy Chain 7
myh9Myosin Heavy Chain 9
MyHCMyosin heavy chain
NAOSneoagaro-oligosaccharides
NaClsodium chloride
NCBINational Center for Biotechnology Information
ODOptical density
qRT-PCRquantitative real-time polymerase chain reaction
SDSsodium dodecyl sulfate
SGLT1sodium–glucose-linked transporter 1

References

  1. Sinha, V.R.; Kumria, R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 2001, 224, 19–38. [Google Scholar] [CrossRef]
  2. Fu, X.T.; Kim, S.M. Agarase: Review of major sources, categories, purification method, enzyme characteristics and applications. Mar. Drugs 2010, 8, 200–218. [Google Scholar] [CrossRef] [PubMed]
  3. Potin, P.; Richard, C.; Rochas, C.; Kloareg, B. Purification and characterization of the α-agarase from Alteromonas agarlyticus (Cataldi) comb. nov., strain GJ1B. Eur. J. Biochem. 1993, 214, 599–607. [Google Scholar] [PubMed]
  4. Kirimura, K.; Masuda, N.; Iwasaki, Y.; Nakagawa, H.; Kobayashi, R.; Usami, S. Purification and characterization of a novel β-agarase from an alkalophilic bacterium, Alteromonas sp. E-1. J. Biosci. Bioeng. 1999, 87, 436–441. [Google Scholar] [PubMed]
  5. Chen, X.; Fu, X.; Huang, L.; Xu, J.; Gao, X. Agar oligosaccharides: A review of preparation, structures, bioactivities and application. Carbohydr. Polym. 2021, 265, 118076. [Google Scholar]
  6. Xu, S.; Kan, J.; Hu, Z.; Liu, Y.; Du, H.; Pang, G.C.; Cheong, K.L. Quantification of Neoagaro-Oligosaccharide Production through Enzymatic Hydrolysis and Its Anti-Oxidant Activities. Molecules 2018, 23, 1354. [Google Scholar] [CrossRef]
  7. Kim, K.H.; Baek, J.H.; Wenting, R.; Jeon, C.O. Rheinheimera maricola sp. nov., isolated from seawater of the Yellow Sea. Int. J. Syst. Evol. Microbiol. 2022, 72, 005423. [Google Scholar]
  8. Manderfeld, E.; Thamaraiselvan, C.; Kleinberg, M.N.; Jusufagic, L.; Arnusch, C.J.; Rosenhahn, A. Bacterial surface attachment and fouling assay on polymer and carbon surfaces using Rheinheimera sp. identified using bacteria community analysis of brackish water. Biofouling 2022, 38, 40–951. [Google Scholar] [CrossRef]
  9. Zhang, W.; Zhu, S.; Cheng, Y.; Ding, L.; Li, S.; Peng, N.; He, S. Rheinheimera mangrovi sp. nov., a bacterium isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol. 2020, 70, 6188–6194. [Google Scholar] [CrossRef]
  10. Fu, J.; Zhong, C.; Zhang, P.; Gao, Q.; Zong, G.; Zhou, Y.; Cao, G. A Novel Mobile Element ICERspD18B in Rheinheimera sp. D18 Contributes to Antibiotic and Arsenic Resistance. Front. Microbiol. 2020, 11, 616364. [Google Scholar] [CrossRef]
  11. Yu, Q.; Qi, Y.; Zhang, H.; Pu, J. Rheinheimera sediminis sp. nov., a marine bacterium isolated from coastal sediment. Int. J. Syst. Microbiol. 2020, 70, 1282–1287. [Google Scholar] [CrossRef] [PubMed]
  12. Zhao, J.; Chen, Z.; Zou, R.; Zhang, X. The application of agar oligosaccharides in directly acidified milk drinks. Food Hydrocoll. 2018, 77, 421–426. [Google Scholar] [CrossRef]
  13. Yun, E.J.; Yu, S.; Kim, Y.-A.; Liu, J.-J.; Kang, N.J.; Jin, Y.-S.; Kim, K.H. In Vitro Prebiotic and Anti-Colon Cancer Activities of Agar-Derived Sugars from Red Seaweeds. Mar. Drugs 2021, 19, 213. [Google Scholar] [CrossRef]
  14. Lee, M.H.; Jang, J.-H.; Yoon, G.Y.; Lee, S.J.; Lee, M.-G.; Kang, T.H.; Han, H.D.; Kim, H.S.; Choi, W.S.; Park, W.S.; et al. Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity. BMB Rep. 2017, 50, 263–268. [Google Scholar] [CrossRef] [PubMed]
  15. Yun, E.J.; Lee, S.; Kim, J.H.; Kim, B.B.; Kim, H.T.; Lee, S.H.; Pelton, J.G.; Kang, N.J.; Choi, I.-G.; Kim, K.H. Enzymatic production of 3,6-anhydro-l-galactose from agarose and its purification and in vitro skin whitening and anti-inflammatory activities. Appl. Microbiol. Biotechnol. 2013, 97, 2961–2970. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, N.; Wang, Q.; Lin, F.; Zheng, B.; Huang, Y.; Yang, Y.; Xue, C.; Xiao, M.; Ye, J. Neoagarotetraose alleviates high fat diet induced obesity via white adipocytes browning and regulation of gut microbiota. Carbohydr. Polym. 2022, 296, 119903. [Google Scholar] [CrossRef]
  17. Zhang, N.; Mao, X.; Li, R.W.; Hou, E.; Wang, Y.; Xue, C.; Tang, Q. Neoagarotetraose protects mice against intense exercise-induced fatigue damage by modulating gut microbial composition and function. Mol. Nutr. Food Res. 2017, 61, 1600585. [Google Scholar] [CrossRef]
  18. Chen, H.; Yan, X.; Zhu, P.; Lin, J. Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo. Nutr. J. 2006, 5, 31. [Google Scholar] [CrossRef]
  19. Hu, B.; Gong, Q.; Wang, Y.; Ma, Y.; Li, J.; Yu, W. Prebiotic effects of neoagaro-oligosaccharides prepared by enzymatic hydrolysis of agarose. Anaerobe 2006, 12, 260–266. [Google Scholar] [CrossRef]
  20. Shirai, I.; Sakai, T.; Shiba, K.; Uzuhashi, Y.; Karasawa, K. Agaro-Oligosaccharides Prevent Myostatin Hyperexpression and Myosin Heavy Chain Protein Degradation in C2C12 Myotubes Induced by Tumor Necrosis Factor-α. CellBio 2018, 6, 23–24. [Google Scholar]
  21. Cheong, K.-L.; Qiu, H.-M.; Du, H.; Liu, Y.; Khan, B.M. Oligosaccharides Derived from Red Seaweed: Production, Properties, and Potential Health and Cosmetic Applications. Molecules 2018, 23, 2451. [Google Scholar] [CrossRef] [PubMed]
  22. Tanji, M.; Wada, K.; Sakamoto, K.; Ono, Y.; Inui, M. Digoxigenin-labeled RNA probes for untranslated regions enable the isoform-specific gene expression analysis of myosin heavy chains in whole-mount in situ hybridization. Dev. Growth Differ. 2022, 65, 48–55. [Google Scholar] [CrossRef] [PubMed]
  23. Jiang, C.; Zhang, T.; Xu, Y.; Mao, X. Characterization of a GH50 β-Agarase: A Biotechnological Tool for Preparing Oligosaccharides from Agarose and Porphyran. Biotechnol. Biol. Transform. 2022, 70, 9931–9940. [Google Scholar] [CrossRef] [PubMed]
  24. Alkotaini, B.; Han, N.S.; Kim, B.S. Fusion of agarase and neoagarobiose hydrolase f or mono-sugar production from agar. Appl. Microbiol. Biotechnol. 2017, 101, 1573–1580. [Google Scholar] [CrossRef]
  25. Liu, G.; Wu, S.; Jin, W.; Sun, C. Amy63, a novel type of marine bacterial multifunctional enzyme possessing amylase, agarase and carrageenase activities. Sci. Rep. 2016, 6, 18726. [Google Scholar] [CrossRef]
  26. Veerakumar, S.; Manian, R. Agarase, Amylase and Xylanase from Halomonas meridiana: A Study on Optimization of Coproduction for Biomass Saccharification. Fermentation 2022, 8, 479. [Google Scholar] [CrossRef]
  27. Roseline, T.L.; Sachindra, N.M. Purification and Characterization of Agarase from Marine Bacteria Acinetobacter sp. PS12B and Its Use for Preparing Bioactive Hydrolysate from Agarophyte Red Seaweed Gracilaria verrucosa. Appl. Biochem. Biotechnol. 2018, 186, 66–84. [Google Scholar] [CrossRef] [PubMed]
  28. Liang, Y.; Ma, X.; Zhang, L.; Li, F.; Liu, Z.; Mao, X. Biochemical Characterization and Substrate Degradation Mode of a Novel Exotype β-Agarase from Agarivorans gilvus WH0801. J. Agric. Food Chem. 2017, 65, 7982–7988. [Google Scholar] [CrossRef]
  29. Li, R.K.; Ying, X.J.; Chen, Z.L.; Ng, T.B.; Zhou, Z.M.; Ye, X.Y. Expression and Characterization of a GH16 Family β-Agarase Derived from the Marine Bacterium Microbulbifer sp. BN3 and Its Efficient Hydrolysis of Agar Using Raw Agar-Producing Red Seaweeds Gracilaria sjoestedtii and Gelidium amansii as Substrates. Catalysts 2020, 10, 885. [Google Scholar] [CrossRef]
  30. Sun, H.; Gao, L.; Xue, C.; Mao, X. Marine-polysaccharide degrading enzymes: Status and prospects. Compr. Rev. Food Sci. Food Saf. 2020, 19, 2767–2796. [Google Scholar] [CrossRef]
  31. Aziz, G.M.; Ali, H.M. Purification and Characterization of Agarase from Bacillus sp., H12. Curr. Res. J. Biol. Sci. 2013, 5, 13–18. [Google Scholar] [CrossRef]
  32. Lin, Y.; Xia, J.; Yang, Z.; Wenju, J. Effect of MnSO4 on the Removal of SO2 by Manganese-Modified Activated Coke. Ind. Eng. Chem. Res. 2015, 54, 1689–1696. [Google Scholar]
  33. Xie, H.; Han, B.; Dong, W.; Yang, Y.; Chang, J.; Peng, Y.; Liu, W. Isolation and characterization of a marine agarase. Acta Microbiol. Sin. 2009, 49, 896–901. [Google Scholar]
  34. Chen, H.M.; Yan, X.J. Antioxidant activities of agaro-oligosaccharides with different degrees of polymerization in cell-based system. Biochim. Biophys. Acta 2004, 1722, 103–111. [Google Scholar] [CrossRef] [PubMed]
  35. Sano, R.; Shinozaki, Y.; Ohta, T. Sodium-glucose cotransporters: Functional properties and pharmaceutical potential. J. Diabetes Investig. 2020, 11, 770–782. [Google Scholar] [CrossRef] [PubMed]
  36. Choudhuri, S.; Chanderbhan, R.F. Chapter 20—The Biology of Nutrients: Genetic and Molecular Principles. Nutraceuticals 2021, 2021, 273–288. [Google Scholar] [CrossRef]
  37. Hong, S.J.; Lee, J.-H.; Kim, E.J.; Yang, H.J.; Chang, Y.-K.; Park, J.-S.; Hong, S.-K. In vitro and in vivo investigation for biological activities of neoagarooligosaccharides prepared by hydrolyzing agar with β-agarase. Biotechnol. Bioprocess Eng. 2017, 22, 489–496. [Google Scholar] [CrossRef]
  38. Deshavath, N.N.; Mukherjee, G.; Goud, V.V.; Veeranki, V.D.; Sastri, C.V. Pitfalls in the 3,5-dinitrosalicylic acid (DNS) assay for the reducing sugars: Interference of furfural and 5-hydroxymethylfurfural. Int. J. Biol. Macromol. 2020, 156, 180–185. [Google Scholar] [CrossRef]
  39. Sun, L.; Miyaji, N.; Yang, M.; Mills, E.M.; Taniyama, S.; Uchida, T.; Nikawa, T.; Li, J.; Shi, J.; Tachibana, K.; et al. Astaxanthin prevents atrophy in slow muscle fibers by inhibiting mitochondrial reactive oxygen species via a mitochondria-mediated apoptosis pathway. Nutrients 2021, 13, 379. [Google Scholar] [CrossRef]
Figure 1. Structure of agar (Chen et al., 2021 and Xu et al., 2018, partly modified) [5,6].
Figure 1. Structure of agar (Chen et al., 2021 and Xu et al., 2018, partly modified) [5,6].
Marinedrugs 22 00515 g001
Figure 2. Agarolytic activity of Rheinheimera sp. (HY) isolated from seawater. (A) Marine bacterium Rheinheimera sp. (HY) on an agar plate, incubated for 48 h. (B) The hydrolysis zone was colored with Lugol’s iodine solution after static incubation for 48 h on an agar plate. (C) Plate-based hydrolytic activity assays for agar, starch, and agarose.
Figure 2. Agarolytic activity of Rheinheimera sp. (HY) isolated from seawater. (A) Marine bacterium Rheinheimera sp. (HY) on an agar plate, incubated for 48 h. (B) The hydrolysis zone was colored with Lugol’s iodine solution after static incubation for 48 h on an agar plate. (C) Plate-based hydrolytic activity assays for agar, starch, and agarose.
Marinedrugs 22 00515 g002
Figure 3. Optimal temperature and pH for crude enzyme activity. (A) Effect of temperature on agarase activity. (B) The optimal pH of agarase’s crude enzyme was measured in 20 mM Na2HPO4/citric acid (pH 3.0, 4.0, and 5.0), 20 mM Na2HPO4/NaH2PO4 (pH 6.0, 7.0, and 8.0), 20 mM Tris/HCl (pH 9.0), and 20 mM Glycin/NaOH (pH 10.0 and 11.0). The mixture was reacted at 30 °C for 30 min to promote enzyme activity by the DNS method. Data are expressed as the mean of triplicate measurements with standard deviation (n = 3, mean ± SD). Data are expressed as mean ± SD. Significance: (A) * p < 0.01, compared with 30 °C. (B) * p < 0.01, compared with pH = 6.
Figure 3. Optimal temperature and pH for crude enzyme activity. (A) Effect of temperature on agarase activity. (B) The optimal pH of agarase’s crude enzyme was measured in 20 mM Na2HPO4/citric acid (pH 3.0, 4.0, and 5.0), 20 mM Na2HPO4/NaH2PO4 (pH 6.0, 7.0, and 8.0), 20 mM Tris/HCl (pH 9.0), and 20 mM Glycin/NaOH (pH 10.0 and 11.0). The mixture was reacted at 30 °C for 30 min to promote enzyme activity by the DNS method. Data are expressed as the mean of triplicate measurements with standard deviation (n = 3, mean ± SD). Data are expressed as mean ± SD. Significance: (A) * p < 0.01, compared with 30 °C. (B) * p < 0.01, compared with pH = 6.
Marinedrugs 22 00515 g003
Figure 4. AOS on C2C12 myotube viability. The myotubes were treated by the AOS mixtures at a concentration of 2000 µg/mL for 24 h. Cell viability was quantified using the Cell Counting Kit-8 (CCK-8) assay. Data are represented as mean ± S.D. (n = 8). Significance: * p < 0.01, compared with control (2% HS/DMEM only culture medium) group.
Figure 4. AOS on C2C12 myotube viability. The myotubes were treated by the AOS mixtures at a concentration of 2000 µg/mL for 24 h. Cell viability was quantified using the Cell Counting Kit-8 (CCK-8) assay. Data are represented as mean ± S.D. (n = 8). Significance: * p < 0.01, compared with control (2% HS/DMEM only culture medium) group.
Marinedrugs 22 00515 g004
Figure 5. Effect of AOS on the diameters of myotubes. (A) Diameters of myotubes in the absence or presence of oligosaccharide mixture for 24 h. Images of myotubes at ×20 magnification; <10 kDa, 10–30 kDa, and >30 kDa oligosaccharide AOS mixture used (at 2000 µg/mL), and 2% HS/DMEM for control. Scale bars indicate 100 µm. (B) Diameters of myotubes in the absence or presence of the oligosaccharide mixture. Myotube diameters were 20 randomly measured myotubes from 10 fields with BZ Analyzer (Keyence, Osaka, Japan). C2C12 myotubes were treated with the AOS mixtures at a concentration of 2000 µg/mL or no treatment as control. Data are represented as mean ± S.D. Significance: * p < 0.01, compared with control group (2% HS/DMEM-only culture medium).
Figure 5. Effect of AOS on the diameters of myotubes. (A) Diameters of myotubes in the absence or presence of oligosaccharide mixture for 24 h. Images of myotubes at ×20 magnification; <10 kDa, 10–30 kDa, and >30 kDa oligosaccharide AOS mixture used (at 2000 µg/mL), and 2% HS/DMEM for control. Scale bars indicate 100 µm. (B) Diameters of myotubes in the absence or presence of the oligosaccharide mixture. Myotube diameters were 20 randomly measured myotubes from 10 fields with BZ Analyzer (Keyence, Osaka, Japan). C2C12 myotubes were treated with the AOS mixtures at a concentration of 2000 µg/mL or no treatment as control. Data are represented as mean ± S.D. Significance: * p < 0.01, compared with control group (2% HS/DMEM-only culture medium).
Marinedrugs 22 00515 g005
Figure 6. Effect of agaro-oligosaccharide mixture on the expression of myosin heavy-chain genes. Myotubes were incubated with the indicated concentrations of 2000 µg/mL oligosaccharides for 24 h. The ratio between the intensities of the myosin heavy-chain genes and 18S rRNA was calculated. Relative myh3 (A), myh7 (B), myh9 (C), and myh4 (D) mRNA were determined by real-time reverse transcription-polymerase chain reactions. Data are represented as mean ± S.D. (n = 4). Significance: * p < 0.05 and ** p < 0.01, compared with control group (2% HS/DMEM-only culture medium).
Figure 6. Effect of agaro-oligosaccharide mixture on the expression of myosin heavy-chain genes. Myotubes were incubated with the indicated concentrations of 2000 µg/mL oligosaccharides for 24 h. The ratio between the intensities of the myosin heavy-chain genes and 18S rRNA was calculated. Relative myh3 (A), myh7 (B), myh9 (C), and myh4 (D) mRNA were determined by real-time reverse transcription-polymerase chain reactions. Data are represented as mean ± S.D. (n = 4). Significance: * p < 0.05 and ** p < 0.01, compared with control group (2% HS/DMEM-only culture medium).
Marinedrugs 22 00515 g006
Table 1. Substrate (agar, agarose, and starch) specificity of Rheinheimera sp. (HY) agarase crude enzymes.
Table 1. Substrate (agar, agarose, and starch) specificity of Rheinheimera sp. (HY) agarase crude enzymes.
SubstrateRelative Activity (%) a,b,c
Agarose100.00 ± 0.01
Agar68.51 ± 2.50 d
Starch28.85 ± 3.58 d
a The mixture was reacted at 30 °C for 30 min. The activity of agarase was then measured according to the amount of reducing sugar by DNS method. b The highest enzymatic activity was defined as 100%. c All data mean values from triplicate experiments. d Data are represented as mean ± S.D. (n = 3). p < 0.05, compared with Agarose.
Table 2. The effect of chemicals on Rheinheimera sp. (HY) agarase’s crude enzyme activity.
Table 2. The effect of chemicals on Rheinheimera sp. (HY) agarase’s crude enzyme activity.
ReagentsRelative Activity (%) a,b,c
Concentration (5 mM)
None100.00 ± 0.01
KCl22.59 ± 4.50 d
MnSO4184.98 ± 12.55 e
FeSO4580.73 ± 144.45 e
NaCl54.63 ± 9.07
EDTA30.13 ± 4.12 d
SDS77.34 ± 5.70
Urea51.86 ± 8.51
a The mixture was reacted at 30 °C for 30 min. The activity of agarase was then measured according to the amount of reducing sugar by DNS method. b The highest enzymatic activity was defined as 100%. c All data mean values from triplicate experiments. d Data are represented as mean ± S.D. (n = 3). p < 0.05, compared with None group. e Data are represented as mean ± S.D. (n = 3). p < 0.01, compared with None group.
Table 3. Glycosidic bond analysis of Rheinheimera sp. (HY) agarase’s crude enzyme activity using artificial chromogenic substrates.
Table 3. Glycosidic bond analysis of Rheinheimera sp. (HY) agarase’s crude enzyme activity using artificial chromogenic substrates.
Artificial Chromogenic SubstratesAbsorbance (OD 420 nm) a
48 h
p-nitrophenyl-α-d-galactopyranoside0.095 ± 0.010
p-nitrophenyl-β-d-galactopyranoside0.071 ± 0.014
a The mixture was reacted at 30 °C for 2 h and terminated by the addition of 1 M Na2CO3. Crude enzymes were from 48 h incubation.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Huang, Y.; Hirose, T.; Tsai, J.-M.; Hirasaka, K. The Effects of Agaro-Oligosaccharides Produced by Marine Bacteria (Rheinheimera sp. (HY)) Possessing Agarose-Degrading Enzymes on Myotube Function. Mar. Drugs 2024, 22, 515. https://doi.org/10.3390/md22110515

AMA Style

Huang Y, Hirose T, Tsai J-M, Hirasaka K. The Effects of Agaro-Oligosaccharides Produced by Marine Bacteria (Rheinheimera sp. (HY)) Possessing Agarose-Degrading Enzymes on Myotube Function. Marine Drugs. 2024; 22(11):515. https://doi.org/10.3390/md22110515

Chicago/Turabian Style

Huang, Youshi, Takuya Hirose, Jyh-Ming Tsai, and Katsuya Hirasaka. 2024. "The Effects of Agaro-Oligosaccharides Produced by Marine Bacteria (Rheinheimera sp. (HY)) Possessing Agarose-Degrading Enzymes on Myotube Function" Marine Drugs 22, no. 11: 515. https://doi.org/10.3390/md22110515

APA Style

Huang, Y., Hirose, T., Tsai, J.-M., & Hirasaka, K. (2024). The Effects of Agaro-Oligosaccharides Produced by Marine Bacteria (Rheinheimera sp. (HY)) Possessing Agarose-Degrading Enzymes on Myotube Function. Marine Drugs, 22(11), 515. https://doi.org/10.3390/md22110515

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop